1649 related articles for article (PubMed ID: 10770210)
41. Clinical significance of a new autoantibody against a human eye muscle soluble antigen, detected by immunofluorescence.
Mengistu M; Laryea E; Miller A; Wall JR
Clin Exp Immunol; 1986 Jul; 65(1):19-27. PubMed ID: 3539423
[TBL] [Abstract][Full Text] [Related]
42. Immunohistochemical studies using immunized Guinea pig sera with features of anti-human thyroid, eye and skeletal antibody and Graves' sera.
Molnár I; Szombathy Z; Kovács I; Szentmiklósi AJ
J Clin Immunol; 2007 Mar; 27(2):172-80. PubMed ID: 17243008
[TBL] [Abstract][Full Text] [Related]
43. A thyroid cytotoxic antibody that cross-reacts with an eye muscle cell surface antigen may be the cause of thyroid-associated ophthalmopathy.
Hiromatsu Y; Fukazawa H; Guinard F; Salvi M; How J; Wall JR
J Clin Endocrinol Metab; 1988 Sep; 67(3):565-70. PubMed ID: 3410941
[TBL] [Abstract][Full Text] [Related]
44. Autoantibodies reactive with extracellular matrix proteins in patients with thyroid-associated ophthalmopathy.
Bednarczuk T; Stolarski C; Pawlik E; Slon M; Rowinski M; Kubota S; Hiromatsu Y; Bartoszewicz Z; Wall JR; Nauman J
Thyroid; 1999 Mar; 9(3):289-95. PubMed ID: 10211607
[TBL] [Abstract][Full Text] [Related]
45. Detection of the novel autoantibody (anti-UACA antibody) in patients with Graves' disease.
Ohkura T; Taniguchi S; Yamada K; Nishio N; Okamura T; Yoshida A; Kamijou K; Fukata S; Kuma K; Inoue Y; Hisatome I; Senju S; Nishimura Y; Shigemasa C
Biochem Biophys Res Commun; 2004 Aug; 321(2):432-40. PubMed ID: 15358194
[TBL] [Abstract][Full Text] [Related]
46. Thyroid-associated ophthalmopathy: clinical features, pathogenesis, and management.
Yamada M; Li AW; Wall JR
Crit Rev Clin Lab Sci; 2000 Dec; 37(6):523-49. PubMed ID: 11192331
[TBL] [Abstract][Full Text] [Related]
47. Patients with endocrine ophthalmopathy not associated with overt thyroid disease have multiple thyroid immunological abnormalities.
Salvi M; Zhang ZG; Haegert D; Woo M; Liberman A; Cadarso L; Wall JR
J Clin Endocrinol Metab; 1990 Jan; 70(1):89-94. PubMed ID: 2294141
[TBL] [Abstract][Full Text] [Related]
48. Serum antibodies reactive with eye muscle antigens and the TSH receptor in a euthyroid subject who developed ophthalmopathy and Graves' hyperthyroidism.
Wall J; Barsouk A; Stolarski C; Kiljanski J; Stachura I; Nebes V; Peele K; Volpe R; Kennerdell J
Thyroid; 1996 Aug; 6(4):353-8. PubMed ID: 8875760
[TBL] [Abstract][Full Text] [Related]
49. A 64 kDa membrane antigen is a recurrent epitope for natural autoantibodies in patients with Graves' thyroid and ophthalmic diseases.
Kendler DL; Rootman J; Huber GK; Davies TF
Clin Endocrinol (Oxf); 1991 Dec; 35(6):539-47. PubMed ID: 1722742
[TBL] [Abstract][Full Text] [Related]
50. Antibodies against calsequestrin and type XIII collagen are good markers for chronic upper eyelid retraction.
Gopinath B; Adams CL; Musselman R; Tani J; Wall JR
Ocul Immunol Inflamm; 2007; 15(2):81-8. PubMed ID: 17558832
[TBL] [Abstract][Full Text] [Related]
51. Isotype and immunoglobulin subclass distribution of eye muscle membrane reactive antibodies in the serum of patients with thyroid-associated ophthalmopathy as detected in Western blotting.
Bernard NF; Ertug F; Teboul N; Zhang ZG; Salvi M; Wall JR
Autoimmunity; 1991; 10(1):57-63. PubMed ID: 1742423
[TBL] [Abstract][Full Text] [Related]
52. Differential autoantibody responses to thyroid peroxidase in patients with Graves' disease and Hashimoto's thyroiditis.
Bermann M; Magee M; Koenig RJ; Kaplan MM; Arscott P; Maastricht J; Johnson J; Baker JR
J Clin Endocrinol Metab; 1993 Oct; 77(4):1098-101. PubMed ID: 8408460
[TBL] [Abstract][Full Text] [Related]
53. Presence of antibodies in the sera of patients with Graves' disease recognizing a 23 kilodalton fibroblast protein.
Bahn RS; Gorman CA; Johnson CM; Smith TJ
J Clin Endocrinol Metab; 1989 Sep; 69(3):622-8. PubMed ID: 2760173
[TBL] [Abstract][Full Text] [Related]
54. [The role of antibodies in Graves' ophthalmopathy].
Molnár I; Balázs C
Orv Hetil; 1991 Sep; 132(38):2097-100. PubMed ID: 1923482
[TBL] [Abstract][Full Text] [Related]
55. Thyroid peroxidase activity-inhibiting immunoglobulins in patients with autoimmune thyroid disease.
Okamoto Y; Hamada N; Saito H; Ohno M; Noh J; Ito K; Morii H
J Clin Endocrinol Metab; 1989 Apr; 68(4):730-4. PubMed ID: 2921308
[TBL] [Abstract][Full Text] [Related]
56. Pathogenesis of thyroid-associated ophthalmopathy: an autoimmune disorder of the eye muscle associated with Graves' hyperthyroidism and Hashimoto's thyroiditis.
Wall JR; Bernard N; Boucher A; Salvi M; Zhang ZG; Kennerdell J; Tyutyunikov A; Genovese C
Clin Immunol Immunopathol; 1993 Jul; 68(1):1-8. PubMed ID: 8513588
[TBL] [Abstract][Full Text] [Related]
57. Identification of thyroglobulin in orbital tissues of patients with thyroid-associated ophthalmopathy.
Marinò M; Lisi S; Pinchera A; Mazzi B; Latrofa F; Sellari-Franceschini S; McCluskey RT; Chiovato L
Thyroid; 2001 Feb; 11(2):177-85. PubMed ID: 11288989
[TBL] [Abstract][Full Text] [Related]
58. [Pathogenesis of thyroid eye disease - does autoimmunity against the TSH receptor explain all cases?].
Wall JR; Lahooti H
Endokrynol Pol; 2011; 62 Suppl 1():1-7. PubMed ID: 22125104
[TBL] [Abstract][Full Text] [Related]
59. Thyroid-associated ophthalmopathy in black South African patients with Graves' disease: relationship to antiflavoprotein antibodies.
Joffe B; Gunji K; Panz V; Zouvanis M; Swanson J; Ackrell BA; Wall JR
Thyroid; 1998 Nov; 8(11):1023-7. PubMed ID: 9848717
[TBL] [Abstract][Full Text] [Related]
60. Significance of tissue specific and tissue non specific autoimmune reactions of Graves' disease.
Kiljanski J; Nebes V; Wall JR
Clin Exp Rheumatol; 1996; 14 Suppl 15():S69-76. PubMed ID: 8828951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
